Lanthanum Carbonate Chewable Tablets
Indications:
Hyperphosphatemia. This product is a phosphate binder for the treatment of hyperphosphatemia in patients with chronic renal failure undergoing hemodialysis or continuous ambulatory peritoneal dialysis (CAPD).
Specifications
500 mg (calculated by lanthanum)
Packaging
High density polyethylene bottle for oral solid medicine, 20 tablets/bottle.